Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)
US 8,846,891 In forceTerm ends Jan 19, 2031 · From the USPTO record
20-year base term ends Aug 7, 2029
Aug 7, 2009
Jan 19, 2031
Sep 30, 2014
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 7, 2009, when this application, 13/060,533, was filed | Aug 7, 2029 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | +530 days, USPTO patent term adjustment record | Jan 19, 2031 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 3 of 3 maintenance fees paid | In force | USPTO record |
| Computed term end | The steps above, in order | Jan 19, 2031 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.